Austin CD, Gonzalez Edick M, Ferrando RE, Solon M, et al. A randomised, placebo-controlled trial evaluating effects of lebrikizumab on airway eosinophilic inflammation and remodelling in uncontrolled asthma (CLAVIER). Clin Exp Allergy 2020 Sep 10. doi: 10.1111/cea.13731.
PMID: 32909660